沙特朝觐者的流感疫苗接种:接种率与接种障碍分析
该研究基于2013、2014和2015年朝觐期间在米纳招募的6974名沙特朝觐者,分析流感疫苗接种率及未接种原因。结果显示,51.3%的朝觐者报告旅行前接种流感疫苗,各年接种率分别为21.4%、48.2%和58.1%(P < 0.001)。缺乏认识(47.5%)、依赖自然免疫(15.8%)和忙碌(15.5%)是未接种的主要原因。
要点
- 2013至2015年沙特朝觐者流感疫苗接种率逐年上升,分别为21.4%、48.2%和58.1%(P < 0.001)。
- 高危朝觐者中54.5%接种了流感疫苗。
- 未接种主要原因为缺乏认识(47.5%)、依赖自然免疫(15.8%)和忙碌(15.5%)。
核心结论
- 来自便利样本的数据表明,沙特朝觐者的流感疫苗接种率逐年上升,但仍需进一步改善;缺乏认识和误解是主要障碍;需要对朝觐者和卫生专业人员进行教育以提高对流感疫苗接种的认识;需要进一步研究以了解朝觐者的误解。
研究设计与样本
- 数据来自2013、2014和2015年朝觐期间参与一项大型试验的沙特朝觐者,在米纳招募并完成基线问卷,记录流感疫苗接种史及未接种原因。
主要发现
- 共招募6974名18至95岁(中位34岁)沙特朝觐者,男女比例为1:1.2。
- 90.8%的朝觐者报告了流感疫苗接种史,其中51.3%报告旅行前接种流感疫苗。
- 2013、2014和2015年的接种率分别为21.4%、48.2%和58.1%(P < 0.001)。
- 1269名重症高风险朝觐者中,54.5%接种了疫苗。
- 未接种的主要原因包括缺乏认识(47.5%)、依赖自然免疫(15.8%)和忙碌(15.5%)。
临床怎么用
- 作者认为需要对沙特朝觐者和卫生专业人员进行教育,以提高对流感疫苗接种的认识。
- 作者建议进一步研究以了解朝觐者的误解。
局限性
- 原文指出数据来自便利样本。
- 原文结论提出需要进一步研究以了解朝觐者的误解。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hajj is the world's largest annual mass gathering that attracts two to three million Muslims from around the globe to a religious assemblage in Makkah, Saudi Arabia. The risk of acquisition and transmission of influenza among Hajj pilgrims is high. Therefore, influenza vaccination is recommended, and was monitored frequently among pilgrims from different countries. However, the vaccination uptake among Saudi pilgrims has not been assessed in recent years. OBJECTIVE: This analysis aims to evaluate influenza vaccine uptake among Saudi Hajj pilgrims, and identify the key barriers to vaccination. METHOD: Data on influenza vaccination were obtained from Saudi pilgrims who took part in a large trial during the Hajj of 2013, 2014 and 2015. Pilgrims were met and recruited in Mina, Makkah during the peak period of Hajj and were asked to complete a baseline questionnaire that recorded their influenza vaccination history, including reason(s) for non-receipt of vaccine. RESULTS: A total of 6974 Saudi pilgrims aged between 18 and 95 (median 34) years were recruited; male to female ratio was 1:1.2. Of the total, 90.8% declared their influenza vaccination history, 51.3% of them reported receiving influenza vaccine before travel to Hajj. The vaccination rates for the years 2013, 2014 and 2015 were 21.4%, 48.2% and 58.1%, respectively (P < 0.001). Of 1,269 pilgrims who were at higher risk of severe disease, 54.5% received the vaccine. Lack of awareness (47.5%), reliance on natural immunity (15.8%) and being busy (15.5%) were the main reasons for non-receipt. CONCLUSION: These data from a convenience sample indicate that influenza vaccine uptake among Saudi Hajj pilgrims is increasing over years but still needs further improvement. Lack of awareness and misperceptions are the main barriers. Education of Saudi pilgrims and health professionals is required to raise awareness about influenza vaccination. Further studies are needed to understand pilgrims' misperceptions.
引用
- Alfelali M, Barasheed O, Badahdah AM, et al. Influenza vaccination among Saudi Hajj pilgrims: Revealing the uptake and vaccination barriers. Vaccine. 2018. PMID: 29555221. doi:10.1016/j.vaccine.2018.03.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。